anayamalik, Author at European Medical Journal - Page 93 of 96

Forecasting Tobacco-Free Generations by 2050

Accelerating the global decline in tobacco smoking could significantly increase life expectancy and prevent millions of premature deaths by 2050, according to new research.

Why Are Breast Cancer Diagnoses Rising?

Breast cancer deaths have declined by 44% since 1989, but rising diagnoses and racial disparities highlight the need for targeted care and early detection.

What Is the Effect of the Pandemic on Mental Health in Youth?

Findings reveal the effect of the pandemic on mental health in youth, showing a significant increase in depression and anxiety diagnoses during COVID-19.

Dupilumab Offers Benefits in Bullous Pemphigoid Management

A clinical trial has shown that dupilumab, a monoclonal antibody targeting IL-4 and IL-13, may offer benefits to patients in managing bullous pemphigoid, a rare autoimmune blistering disease.

Concerns With Pediatric Pneumonia Treatment In The U.S. Revealed

New Two-Dose Method Strengthens HIV Vaccine Response

A study highlights a significant advancement in HIV vaccine development: a two-dose priming strategy that optimizes the body’s immune response by aligning vaccine delivery with the germinal center (GC) reaction.

Advanced Imaging Techniques to Transform Arthritis Diagnosis

Adoption of cutting-edge imaging technologies and innovative use of existing methods may revolutionize the diagnosis and treatment of inflammatory arthritis.

BRCA Testing in Male Patients Slipping Through the Net

Greater BRCA genetic testing among men has been highlighted as a critical need in a recently published review

HFSA Cancels Annual Scientific Meeting Due to Hurricane Helene

The Heart Failure Society of America (HFSA) has made the difficult decision to cancel its 2024 Annual Scientific Meeting and the Devices in Heart Failure Meeting, originally scheduled for September 27-30 in Atlanta, Georgia.

RSV Threatens 50% of Healthy Infants Under 1

A new study reveals that over half of healthy U.S. infants contract respiratory syncytial virus in their first year, with 44.1% developing lower respiratory tract infections.